These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30738289)

  • 1. Characteristics and prognosis of stage I-III breast cancer subtypes in Brazil: The AMAZONA retrospective cohort study.
    Simon SD; Bines J; Werutsky G; Nunes JS; Pacheco FC; Segalla JG; Gomes AJS; Adam Van Eyll BMHR; Gimenes DL; Crocamo S; Freitas-Junior R; Lago LD; Queiroz GS; Jobim de Azevedo S; Rosa DD; Delgado G; Borges GS; Verônica do Nascimento Y; Zaffaroni F; Martínez-Mesa J; Barrios CHE
    Breast; 2019 Apr; 44():113-119. PubMed ID: 30738289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical features and prognosis analysis of different breast cancer molecular subtypes].
    Yang Q; Chen J; Li HJ; Yu M; Tian CX; Lü Q
    Zhonghua Zhong Liu Za Zhi; 2011 Jan; 33(1):42-6. PubMed ID: 21575463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of molecular subtype on breast cancer recurrence in young women treated with contemporary adjuvant therapy.
    Alabdulkareem H; Pinchinat T; Khan S; Landers A; Christos P; Simmons R; Moo TA
    Breast J; 2018 Mar; 24(2):148-153. PubMed ID: 28707744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical features and prognosis of patients with first-episode liver metastasis of different molecular subtypes of breast cancer].
    Wu SY; Tan Y; Guan YS
    Zhonghua Gan Zang Bing Za Zhi; 2016 Jun; 24(6):422-8. PubMed ID: 27465945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical characteristics and survival in the operable breast cancer patients with different molecular subtypes].
    Zhang HM; Zhang BN; Xuan LX; Zhao P
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):447-51. PubMed ID: 19950556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical characteristics and prognosis of different subtypes of breast cancer].
    Yuan ZY; Wang SS; Zhu MQ; Zheng L; Luo WB; Zhou ZM; Guan ZZ
    Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):456-61. PubMed ID: 19024523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different prognosis of young breast cancer patients in their 20s and 30s depending on subtype: a nationwide study from the Korean Breast Cancer Society.
    Ryu JM; Yu J; Kim SI; Kim KS; Moon HG; Choi JE; Jeong J; Do Byun K; Nam SJ; Lee JE; Lee SK; Kim SW
    Breast Cancer Res Treat; 2017 Dec; 166(3):833-842. PubMed ID: 28831642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is biological subtype prognostic of locoregional recurrence risk in women with pT1-2N0 breast cancer treated with mastectomy?
    Truong PT; Sadek BT; Lesperance MF; Alexander CS; Shenouda M; Raad RA; Taghian AG
    Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):57-64. PubMed ID: 24161421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity is an independent prognostic factor of decreased pathological complete response to neoadjuvant chemotherapy in breast cancer patients.
    Karatas F; Erdem GU; Sahin S; Aytekin A; Yuce D; Sever AR; Babacan T; Ates O; Ozisik Y; Altundag K
    Breast; 2017 Apr; 32():237-244. PubMed ID: 27318645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer in young women from a low risk population in Nepal.
    Thapa B; Singh Y; Sayami P; Shrestha UK; Sapkota R; Sayami G
    Asian Pac J Cancer Prev; 2013; 14(9):5095-9. PubMed ID: 24175782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of sociodemographic factors and health insurance coverage in the diagnosis and clinicopathological characteristics of breast cancer in Brazil: AMAZONA III study (GBECAM 0115).
    Rosa DD; Bines J; Werutsky G; Barrios CH; Cronemberger E; Queiroz GS; de Lima VCC; Freitas-Júnior R; Couto JD; Emerenciano K; Resende H; Crocamo S; Reinert T; Van Eyil B; Nerón Y; Dybal V; Lazaretti N; de Cassia Costamilan R; de Andrade DAP; Mathias C; Vacaro GZ; Borges G; Morelle A; Caleffi M; Filho CS; Mano MS; Zaffaroni F; de Jesus RG; Simon SD
    Breast Cancer Res Treat; 2020 Oct; 183(3):749-757. PubMed ID: 32728860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stage-to-stage comparison of neoadjuvant chemotherapy versus adjuvant chemotherapy in pathological lymph node positive breast cancer patients.
    Lee NK; Shin KH; Park IH; Lee KS; Ro J; Jung SY; Lee S; Kim SW; Kim TH; Kim JY; Kang HS; Cho KH
    Jpn J Clin Oncol; 2012 Nov; 42(11):995-1001. PubMed ID: 22911001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local radiotherapy alone following neoadjuvant chemotherapy and surgery in combined clinical stage II and III breast cancer.
    White R; Dinneen T; Makris A
    Radiat Oncol; 2016 Jul; 11():93. PubMed ID: 27457764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analyses.
    Yang Y; Im SA; Keam B; Lee KH; Kim TY; Suh KJ; Ryu HS; Moon HG; Han SW; Oh DY; Han W; Kim TY; Park IA; Noh DY
    BMC Cancer; 2016 Jul; 16():515. PubMed ID: 27444430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic value of triple negative in stage II/III breast cancer.
    Elnashar AT; Ali el-SM; Gaber A
    J Oncol Pharm Pract; 2012 Mar; 18(1):68-75. PubMed ID: 21422149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The influence of molecular classification of breast cancer on the safety of breast-conserving surgery].
    Li Y; Mu L; Ruan YX; Wang YT; Zhang D; Zhou H; Wang X
    Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):341-346. PubMed ID: 29860760
    [No Abstract]   [Full Text] [Related]  

  • 17. Analysis of the relevance between molecular subtypes and efficacy of neoadjuvant chemotherapy in breast cancer as well as its prognostic factors.
    Li F; Ma L; Geng C; Liu C; Deng H; Yue M; Ding Y; Wang X; Liu Y
    Pathol Res Pract; 2018 Aug; 214(8):1166-1172. PubMed ID: 29945816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study.
    Sanpaolo P; Barbieri V; Genovesi D
    Eur J Surg Oncol; 2011 Oct; 37(10):876-82. PubMed ID: 21824742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant chemotherapy increases rates of breast-conserving surgery in early operable breast cancer.
    Man VC; Cheung PS
    Hong Kong Med J; 2017 Jun; 23(3):251-7. PubMed ID: 28484080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Female patients with breast carcinoma age 30 years and younger have a poor prognosis: the M.D. Anderson Cancer Center experience.
    Xiong Q; Valero V; Kau V; Kau SW; Taylor S; Smith TL; Buzdar AU; Hortobagyi GN; Theriault RL
    Cancer; 2001 Nov; 92(10):2523-8. PubMed ID: 11745185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.